PharmaEssentia Corporation (TPE:6446)
Taiwan
· Delayed Price · Currency is TWD 513.00
-4.00 (-0.77%)
Dec 5, 2025, 1:35 PM CST
PharmaEssentia Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 189,732 | 204,725 | 114,578 | 143,840 | 78,065 | 24,709 | Upgrade
|
| Market Cap Growth | -8.20% | 78.68% | -20.34% | 84.26% | 215.94% | 2.44% | Upgrade
|
| Enterprise Value | 169,043 | 184,915 | 94,836 | 140,322 | 77,603 | 21,027 | Upgrade
|
| Last Close Price | 513.00 | 552.99 | 311.12 | 428.91 | 260.17 | 83.29 | Upgrade
|
| PE Ratio | 39.62 | 69.04 | - | - | - | - | Upgrade
|
| Forward PE | 27.46 | 41.36 | 31.89 | 69.03 | - | - | Upgrade
|
| PS Ratio | 13.73 | 21.03 | 22.44 | 49.91 | 118.91 | 44.34 | Upgrade
|
| PB Ratio | 6.38 | 7.45 | 4.78 | 11.85 | 18.37 | 6.30 | Upgrade
|
| P/TBV Ratio | 6.43 | 7.53 | 4.84 | 12.08 | 19.50 | 6.68 | Upgrade
|
| P/FCF Ratio | 62.71 | 121.51 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 43.97 | 80.38 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 12.24 | 19.00 | 18.58 | 48.69 | 118.21 | 37.73 | Upgrade
|
| EV/EBITDA Ratio | 39.77 | 100.14 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 43.28 | 106.51 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 55.88 | 109.75 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.05 | 0.13 | 0.13 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.47 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.30 | 0.57 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.43 | 0.33 | 0.24 | 0.27 | 0.11 | 0.13 | Upgrade
|
| Inventory Turnover | 1.22 | 0.86 | 0.48 | 0.83 | 0.60 | 1.15 | Upgrade
|
| Quick Ratio | 6.45 | 9.34 | 9.86 | 4.37 | 2.80 | 3.37 | Upgrade
|
| Current Ratio | 6.83 | 9.94 | 10.64 | 5.24 | 3.49 | 3.82 | Upgrade
|
| Return on Equity (ROE) | 17.21% | 11.54% | -3.46% | -16.77% | -68.81% | -63.10% | Upgrade
|
| Return on Assets (ROA) | 7.68% | 3.72% | -5.61% | -11.77% | -30.08% | -25.26% | Upgrade
|
| Return on Capital (ROIC) | 8.46% | 4.05% | -6.16% | -13.71% | -37.72% | -29.60% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.80% | 6.10% | -7.60% | -15.90% | -59.00% | -38.60% | Upgrade
|
| Earnings Yield | 2.53% | 1.45% | -0.54% | -0.96% | -3.60% | -7.88% | Upgrade
|
| FCF Yield | 1.59% | 0.82% | -1.74% | -1.26% | -3.24% | -6.22% | Upgrade
|
| Dividend Yield | 0.19% | 0.18% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.44% | -3.59% | -13.47% | -9.24% | -7.39% | -10.55% | Upgrade
|
| Total Shareholder Return | -0.25% | -3.41% | -13.47% | -9.24% | -7.39% | -10.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.